Folgen
Dr.Partha Pratim Roy
Dr.Partha Pratim Roy
Guru Ghasidas University
Bestätigte E-Mail-Adresse bei ggu.ac.in
Titel
Zitiert von
Zitiert von
Jahr
On some aspects of variable selection for partial least squares regression models
PP Roy, K Roy
QSAR & Combinatorial Science 27 (3), 302-313, 2008
8852008
On two novel parameters for validation of predictive QSAR models
P Pratim Roy, S Paul, I Mitra, K Roy
Molecules 14 (5), 1660-1701, 2009
6392009
Exploring the impact of size of training sets for the development of predictive QSAR models
PP Roy, JT Leonard, K Roy
Chemometrics and Intelligent Laboratory Systems 90 (1), 31-42, 2008
3292008
QSAR modeling is not “push a button and find a correlation”: a case study of toxicity of (benzo‐) triazoles on algae
P Gramatica, S Cassani, PP Roy, S Kovarich, CW Yap, E Papa
Molecular Informatics 31 (11‐12), 817-835, 2012
2152012
1, 3, 4-Oxadiazoles: An emerging scaffold to target growth factors, enzymes and kinases as anticancer agents
S Bajaj, V Asati, J Singh, PP Roy
European journal of medicinal chemistry 97, 124-141, 2015
1632015
Comparative chemometric modeling of cytochrome 3A4 inhibitory activity of structurally diverse compounds using stepwise MLR, FA-MLR, PLS, GFA, G/PLS and ANN techniques
K Roy, PP Roy
European journal of medicinal chemistry 44 (7), 2913-2922, 2009
1522009
Daphnia and fish toxicity of (benzo) triazoles: Validated QSAR models, and interspecies quantitative activity–activity modelling
S Cassani, S Kovarich, E Papa, PP Roy, L van der Wal, P Gramatica
Journal of hazardous materials 258, 50-60, 2013
1252013
On further application of r as a metric for validation of QSAR models
I Mitra, PP Roy, S Kar, PK Ojha, K Roy
Journal of Chemometrics: A Journal of the Chemometrics Society 24 (1), 22-33, 2010
1032010
QSAR studies of CYP2D6 inhibitor aryloxypropanolamines using 2D and 3D descriptors
PP Roy, K Roy
Chemical biology & drug design 73 (4), 442-455, 2009
972009
QSAR model reproducibility and applicability: A case study of rate constants of hydroxyl radical reaction models applied to polybrominated diphenyl ethers and (benzo‐) triazoles
PP Roy, S Kovarich, P Gramatica
Journal of computational chemistry 32 (11), 2386-2396, 2011
762011
Comparative QSAR studies of CYP1A2 inhibitor flavonoids using 2D and 3D descriptors
K Roy, PP Roy
Chemical biology & drug design 72 (5), 370-382, 2008
692008
Molecular docking and QSAR studies of aromatase inhibitor androstenedione derivatives
PP Roy, K Roy
Journal of Pharmacy and Pharmacology 62 (12), 1717-1728, 2010
492010
QSAR of adenosine receptor antagonists: Exploring physicochemical requirements for binding of pyrazolo [4, 3-e]-1, 2, 4-triazolo [1, 5-c] pyrimidine derivatives with human …
DP Kishore, C Balakumar, AR Rao, PP Roy, K Roy
Bioorganic & medicinal chemistry letters 21 (2), 818-823, 2011
482011
QSAR of cytochrome inhibitors
K Roy, PP Roy
Expert Opinion on Drug Metabolism & Toxicology 5 (10), 1245-1266, 2009
442009
Synthesis, thymidine phosphorylase inhibitory and computational study of novel 1, 3, 4-oxadiazole-2-thione derivatives as potential anticancer agents
S Bajaj, PP Roy, J Singh
Computational Biology and Chemistry 76, 151-160, 2018
412018
1, 3, 4-oxadiazoles as telomerase inhibitor: Potential anticancer agents
S Bajaj, PP Roy, J Singh
Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2017
382017
QSPR of the bioconcentration factors of non-ionic organic compounds in fish using extended topochemical atom (ETA) indices
K Roy, I Sanyal, PP Roy
SAR and QSAR in Environmental Research 17 (6), 563-582, 2006
372006
Docking and 3D-QSAR studies of diverse classes of human aromatase (CYP19) inhibitors
PP Roy, K Roy
Journal of molecular modeling 16, 1597-1616, 2010
362010
Exploring QSAR and QAAR for inhibitors of cytochrome P450 2A6 and 2A5 enzymes using GFA and G/PLS techniques
K Roy, PP Roy
European journal of medicinal chemistry 44 (5), 1941-1951, 2009
322009
Synthesis and evaluation of anticancer activity of 1, 3, 4-oxadiazole derivatives against Ehrlich ascites carcinoma bearing mice and their correlation with histopathology of liver
PP Roy, S Bajaj, TK Maity, J Singh
Indian J Pharm Educ 15, 16, 2017
292017
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20